Accuracy of Non-Invasive Prenatal Testing (NIPT) for Fetal Sex Determination at 9 Weeks
Non-invasive prenatal testing (NIPT) using cell-free DNA (cfDNA) at 9 weeks gestation demonstrates high accuracy for fetal sex determination, with sensitivity of approximately 96.6% and specificity of 98.9%. 1
NIPT Performance for Fetal Sex Determination
- NIPT for fetal sex determination can be performed after 9-10 weeks gestation, as approximately 10-15% of the total cell-free DNA in maternal plasma is of placental origin by this time 2
- The accuracy of NIPT for fetal sex determination does not significantly vary by trimester or week of testing after 9 weeks, maintaining reliably high performance throughout pregnancy 1
- Meta-analysis of studies incorporating 9,965 pregnancies showed overall mean sensitivity of 96.6% (95% CI: 95.2-97.7%) and mean specificity of 98.9% (95% CI: 98.1-99.4%) for fetal sex determination using cfDNA 1
Factors Affecting NIPT Accuracy at 9 Weeks
- Approximately 1% of initial samples submitted for NIPT result in "no-call" results, with insufficient fetal fraction being the most common cause 2
- Maternal factors that can reduce accuracy at 9 weeks include:
- Fetal factors that may affect accuracy include:
Comparison with Ultrasound for Fetal Sex Determination
- Ultrasound determination of fetal sex at 9 weeks (equivalent to 11 weeks gestational age) has significantly lower accuracy than NIPT:
Clinical Implications
- NIPT provides a reliable non-invasive alternative to invasive testing for sex determination in pregnancies at risk of sex-linked genetic disorders 2
- For pregnancies requiring sex determination at 9 weeks, NIPT is significantly more accurate than ultrasound at this early gestational age 4, 1
- If a "no-call" result occurs with NIPT at 9 weeks, repeat testing at a slightly later gestational age provides a result in approximately 75-80% of cases 2
- The American College of Obstetricians and Gynecologists recommends offering diagnostic testing to individuals with persistent no-call results 2
Important Considerations
- NIPT for fetal sex determination should be performed in the context of appropriate pre-test and post-test genetic counseling 2
- Patients should be informed that while highly accurate, NIPT is a screening test, not a diagnostic test, and any abnormal or uncertain results should be confirmed with diagnostic testing 2
- The American College of Medical Genetics and Genomics (ACMG) strongly recommends NIPT over traditional screening methods for both singleton and twin pregnancies 2
- Alternative screening methods should be considered for women with factors predisposing to low fetal fraction, such as high BMI 3